Swift Biosciences' Series A - II Round

Swift Biosciences raised a round of funding on February 13, 2012. Investors include Mercury Fund.

Swift Biosciences is focused on developing innovative enabling technologies for genomics and personalized medicine. With the launch of its line of Accel-NGS products, Swift is now applying its unique …

Articles about Swift Biosciences' Series A - II Round: